Reduction of health status 7 years after addition of chemotherapy to craniospinal irradiation for medulloblastoma: a follow-up study in PNET 3 trial survivors on behalf of the CCLG (formerly UKCCSG).

Bull, Kim S; Spoudeas, Helen A; Yadegarfar, Ghasem; Kennedy, Colin R

Bull, Kim S; Spoudeas, Helen A; Yadegarfar, Ghasem; Kennedy, Colin R.

Affiliation

Bull KS; Department of Child Health and Research and Development Support Unit, University of Southampton, Southampton, UK.

J Clin Oncol ; 25(27): 4239-45, 2007 Sep 20.

Article in En | MEDLINE | ID: mdl-17878477

Subject(s)

Cranial Irradiation/adverse effects; Medulloblastoma/radiotherapy; Adolescent; Adult; Brain Neoplasms/radiotherapy; Child; Clinical Trials as Topic; Follow-Up Studies; Health Status; Humans; Quality of Life; Spinal Neoplasms/radiotherapy; Survivors; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Cranial Irradiation / Medulloblastoma Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Humans Language: En Journal: J Clin Oncol Year: 2007 Type: Article Affiliation country: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links